Clinical Trials

40 enrolled

Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT07528352 2026-04-17

REBEL

Lymphoma, Large B-Cell, Diffuse

NCT07537049 2026-04-17

BR101 in Patients With Relapsed/Refractory Multiple Myeloma

10 enrolled

Plasma cell

Multiple Myeloma

NCT07532525 2026-04-16

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

Burkitt Lymphoma, Lymphoma, B-Cell

NCT07532746 2026-04-16

A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

55 enrolled

Recurrence, Hematologic Neoplasms

NCT07533708 2026-04-16

A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours

48 enrolled

mCRPC or Advanced/Metastatic Solid Tumors

NCT07535112 2026-04-16

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

130 enrolled

Gastrointestinal

Advanced/Metastatic Colorectal Adenocarcinoma

NCT01481532 2026-04-15

Open Label Clinical Trial of Intravenous Crotoxin Part 3

Tumor-Agnostic

Neoplasms

NCT07485569 2026-04-15

REPOTHYROID-II

10 enrolled

EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT07493174 2026-04-15

Phase I Clinical Study to Evaluate SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Malignancies

86 enrolled

Recurrence

NCT07518043 2026-04-15

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

DermatologicGenitourinary

174 enrolled

Carcinoma, Transitional Cell, Melanoma

NCT07531095 2026-04-15

DeLLphi-313

160 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07532148 2026-04-15

Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Gynecologic

Ovarian Neoplasms

NCT06941480 2026-04-14

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

Endocrine

Carcinoma, Neuroendocrine

NCT07221032 2026-04-14

FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma

Plasma cell

Multiple Myeloma

NCT07527221 2026-04-14

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

MyeloidOther hematologic neoplasm

40 enrolled

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07529951 2026-04-14

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

60 enrolled

Myeloid

Polycythemia Vera, Primary Myelofibrosis

NCT06982222 2026-04-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07012044 2026-04-13

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

47 enrolled

Leukemia, Myeloid, Acute

NCT07156227 2026-04-13

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

39 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07297667 2026-04-13

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT07332507 2026-04-13

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

Plasmablastic Lymphoma

NCT07408258 2026-04-13

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

20 enrolled

Advanced Solid Tumor

NCT07422363 2026-04-13

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT07444710 2026-04-13

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

16 enrolled

Ann Arbor Stage II Mantle Cell Lymphoma

NCT07513129 2026-04-13

A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And Lymphomas

LymphoidOther hematologic neoplasm

18 enrolled

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07523464 2026-04-13

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

Thoracic

Locally-Advanced Non-Small Cell Lung Cancer

NCT07524140 2026-04-13

Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts.

60 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07524322 2026-04-13

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

63 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07525141 2026-04-13

A Study of JNJ-1761981 in Participants With Solid Tumors

66 enrolled

Tumor-Agnostic

Neoplasms

NCT07519564 2026-04-09

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

18 enrolled

Cachexia, Neoplasms

NCT07519655 2026-04-09

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

DermatologicGastrointestinalThoracic

250 enrolled

Esophageal Neoplasms, Lung Neoplasms, Melanoma

NCT07408856 2026-04-08

CAN1012 in Pre-Malignant DCIS and LCIS

Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT07518329 2026-04-08

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

LymphoidOther hematologic neoplasm

46 enrolled

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT07518654 2026-04-08

ThINKK-01

CNSLymphoidOther hematologic neoplasm

Paroxysmal nonkinesigenic dyskinesia, Leukemia, Neoplasm Metastasis, Neuroblastoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07170592 2026-04-07

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients

Treatment-Refractory Solid Tumors

NCT07200089 2026-04-07

Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)

52 enrolled

Plasma cell

Multiple Myeloma

NCT07254793 2026-04-07

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

LymphoidMyeloidOther hematologic neoplasm

94 enrolled

Lymphoma, Non-Hodgkin, Motor Activity, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07426757 2026-04-07

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

120 enrolled

Advanced Malignancies

NCT07513194 2026-04-07

GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)

21 enrolled

Simpson-Golabi-Behmel syndrome, Rhabdoid Tumor

NCT07511062 2026-04-06

Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML

32 enrolled

Leukemia, Myeloid, Acute

NCT07374029 2026-04-03

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Leukemia, Myeloid, Acute

NCT07476326 2026-04-03

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

120 enrolled

Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

NCT07340190 2026-04-02

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

Advanced Malignancies

NCT07422610 2026-04-02

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

Lymphoma, Follicular

NCT07488923 2026-04-01

SPECTRAL-1

110 enrolled

EndocrineThoracic

Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT07075120 2026-03-31

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

15 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT07176975 2026-03-31

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

46 enrolled